Desloratadine
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 708 publications
Experts' view on the management of scalp seborrheic dermatitis in Italy.
Journal: The Journal of dermatological treatment
Published: March 23, 2026
'Oral isotretinoin plus desloratadine for acne vulgaris: an updated global meta-analysis of efficacy, safety, and patient-centered outcomes'.
Journal: The Journal of dermatological treatment
Published: March 17, 2026
Optical control of H1 receptor signaling with a BODIPY-photocaged antihistamine.
Journal: Biochemical pharmacology
Published: November 25, 2025
Efficacy comparison of combined montelukast-antihistamine and montelukast monotherapy in allergic rhinitis: a meta-analysis of randomized controlled trials.
Journal: European annals of allergy and clinical immunology
Published: October 31, 2025
Desloratadine Induces TP53-Dependent Apoptosis in MCF-7 Breast Cancer Cells.
Journal: Cells
Published: October 09, 2025
Investigation of the Immune System Effects of Desloratadine on Lipopolysaccharide-Stimulated Mammalian Macrophage Cells.
Journal: Fundamental & clinical pharmacology
Published: October 03, 2025
Desloratadine as an adjunct to isotretinoin: enhancing tolerability and adherence in acne management.
Journal: Annals of medicine and surgery (2012)
Published: September 07, 2025
Risk of injury associated with the sedative potential of second-generation antihistamines: A nationwide retrospective cohort study.
Journal: British journal of clinical pharmacology
Published: August 19, 2025
Administration of Desloratadine for Postorgasmic Illness Syndrome in a Japanese Teenager.
Journal: IJU case reports
Published: August 04, 2025
Investigation of the impacts of second-generation antihistamines on free-living marine nematodes and their interaction with ZnS nanoparticles: Mechanistic insights from community and population approaches and molecular interactions modeling.
Journal: Marine environmental research
Published: August 03, 2025
Second-Generation H1-Receptor Antagonists, Mequitazine, Azelastine and Desloratadine Activate Caspase-8, Caspase-3, and Gasdermin E and Induce Cell Death Showing Pyroptotic-Like Features in Macrophages at Excessively High Concentrations.
Journal: Biological & pharmaceutical bulletin
Published: July 16, 2025
Last Updated: 04/28/2026